Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 78/100

Tandem Diabetes Care Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 08:40PM GMT
Release Date Price: €29.76 (-1.91%)
Travis Lee Steed
BofA Securities, Research Division - MD

Good afternoon, everybody. Next up, we have Tandem Diabetes. I'm Travis Steed, the medical device analyst at BofA. We have John Sheridan, CEO; and Leigh Vosseller, CFO. So welcome, and I think John, you wanted to...

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Sure. I just want to kind of give you guys a sense of the state. Thank you for having us Travis. It's always great to be here. We prefer to be on the West Coast and in at least the same time zone that we kind of are from, it's a lot easier getting up in the morning and having those early meetings.

So I guess I wanted to start off by saying that we've been pretty clear over the last quarter, couple of quarters that there's been a good deal of pressure on the business from the macroeconomic factors and from the competitive issues as well. And I would say that as we enter this year, we have seen some stabilization, which has been good.

The stabilization doesn't mean we're not experiencing pressure.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot